Another report by Kaufman et al., showed an increase in MART-1 CD8+ T cells and IFN-gamma produced by tumor infiltrating lymphocytes (TILs) in injected lesions undergoing regression after vaccination compared with T-cells derived from lesions of untreated melanoma patients. This evidence concerns the gene MLANA and melanoma.